author-photo

David Valdecanas

University of Texas MD Anderson Cancer Center

48

Papers

1421

Citations

Citation Trend

Filter By

Papers (36) Sort By

Journal Conference Others

p16 Expression Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade.

2021
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 2919: p16 modulates a novel ubiquitin signaling cascade which regulates radioresponse and offers clinically relevant therapeutic targets in squamous cell carcinoma

2019 Tumor Biology
Show All
- Source
- Cite
- Save
Citations (0)
Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cells

2018 Cancer Letters
Show All
- Source
- Cite
- Save
Citations (34)
Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy.

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (131)
TRIP12 as a mediator of human papillomavirus/p16-related radiation enhancement effects.

2017 Oncogene
Show All
- Source
- Cite
- Save
Citations (27)
BAP1 Is a Novel Target in HPV-Negative Head and Neck Cancer

2017 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (15)
Targeting anti-PD1-resistant tumors via indoleamine 2,3-dioxygenase 1 (IDO1) inhibition.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Suppression of Major Histocompatibility Complex (MHC) Class I and II Mediates Resistance to Anti-PD-1 in Lung Adenocarcinoma Tumors That Can Be Overcome by Radiation Therapy

2016 International Journal of Radiation Oncology Biology Physics
Show All
- Source
- Cite
- Save
Citations (3)
PDL1 Regulation by p53 via miR-34

2016 Journal of the National Cancer Institute
Show All
- Source
- Cite
- Save
Citations (334)
Abstract 1661: TRIP12 as a mediator of human papillomavirus/p16-related radiation enhancement effects

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)